GB Sciences, Inc. (GBLX)
OTCMKTS: GBLX · Delayed Price · USD
0.0063
+0.0001 (2.11%)
Apr 25, 2024, 3:16 PM EDT - Market closed
GB Sciences Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 0.11 | 0.23 | 0.79 | 0.15 | 0.23 | 3.58 | 2.69 | 0.03 | 0 | 0.34 | Upgrade
|
Cash & Cash Equivalents | 0.11 | 0.23 | 0.79 | 0.15 | 0.23 | 3.58 | 2.69 | 0.03 | 0 | 0.34 | Upgrade
|
Cash Growth | -53.01% | -70.51% | 422.54% | -33.37% | -93.64% | 32.93% | 7633.04% | - | - | 13881.33% | Upgrade
|
Receivables | 0 | 0 | 0 | 5.34 | 0.49 | 0.67 | 0 | 0.07 | 0.05 | 0.15 | Upgrade
|
Inventory | 0 | 0 | 0 | 1.45 | 2.14 | 1.05 | 0.09 | 0 | 0 | -0.15 | Upgrade
|
Other Current Assets | 0.2 | 0.09 | 2.75 | 0.06 | 0.61 | 1.96 | 0.17 | 0.1 | 0.19 | 0.15 | Upgrade
|
Total Current Assets | 0.31 | 0.33 | 3.54 | 7 | 3.47 | 7.25 | 2.95 | 0.21 | 0.24 | 0.49 | Upgrade
|
Property, Plant & Equipment | 0 | 0 | 0.03 | 5.56 | 23.5 | 13.76 | 8.64 | 1.95 | 0.91 | 0.04 | Upgrade
|
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | -9,657,004.54 | 0 | 0 | 0 | 0 | Upgrade
|
Goodwill | -42,818.96 | -2,222,071.78 | -1,706,760.29 | -1,699,964.3 | -1,818,800.18 | 1.4 | 0 | 0 | 0 | 0 | Upgrade
|
Intangible Assets | 42,819 | 2,222,074 | 1,706,762 | 1,699,966 | 1,818,802 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Long-Term Assets | 0 | 0 | 5.53 | 0.09 | 1.23 | 9,657,006 | 1.42 | 0.27 | 0.29 | 0 | Upgrade
|
Total Long-Term Assets | 0.04 | 2.22 | 7.26 | 7.35 | 26.56 | 16.8 | 10.06 | 2.23 | 1.21 | 0.05 | Upgrade
|
Total Assets | 0.35 | 2.55 | 10.81 | 14.35 | 30.02 | 24.05 | 13.01 | 2.44 | 1.45 | 0.54 | Upgrade
|
Accounts Payable | 1.86 | 1.66 | 1.41 | 2.56 | 3.07 | 0.37 | 0.18 | 0.9 | 0.68 | 0.02 | Upgrade
|
Deferred Revenue | 958,455 | 0 | 2.21 | 0 | 0.51 | 0 | 0 | 0 | 0.05 | 0 | Upgrade
|
Current Debt | 1.4 | 0.99 | 4.16 | 5.86 | 2.53 | 1.06 | 0 | 0.46 | 0.03 | 1.27 | Upgrade
|
Other Current Liabilities | -958,453.5 | 1.29 | 0.81 | 2.47 | 0.61 | 0.49 | 0.5 | 0.9 | 0.22 | 0.26 | Upgrade
|
Total Current Liabilities | 4.76 | 3.94 | 8.6 | 10.89 | 6.71 | 1.92 | 0.68 | 2.26 | 0.98 | 1.55 | Upgrade
|
Long-Term Debt | 0 | 0.4 | 0.29 | 3.56 | 6.16 | 6.5 | 3.93 | 2.15 | 0 | 0 | Upgrade
|
Other Long-Term Liabilities | 0 | 0 | 3.39 | 0 | 0 | 0 | 0 | 0 | 0.22 | 0 | Upgrade
|
Total Long-Term Liabilities | 0 | 0.4 | 3.68 | 3.56 | 6.16 | 6.5 | 3.93 | 2.15 | 0.22 | 0 | Upgrade
|
Total Liabilities | 4.76 | 4.33 | 12.28 | 14.44 | 12.87 | 8.42 | 4.6 | 4.41 | 1.21 | 1.55 | Upgrade
|
Total Debt | 1.4 | 1.38 | 4.46 | 9.42 | 8.68 | 7.55 | 3.93 | 2.61 | 0.03 | 1.27 | Upgrade
|
Debt Growth | 0.81% | -68.93% | -52.67% | 8.42% | 14.97% | 92.25% | 50.43% | 8606.96% | -97.63% | 89.17% | Upgrade
|
Common Stock | 0.04 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | 0 | 0 | 0 | Upgrade
|
Retained Earnings | -108.71 | -104.58 | -103.89 | -97.39 | -84.74 | -58.23 | -35.26 | -20.78 | -14.01 | -6.21 | Upgrade
|
Comprehensive Income | 0 | 0 | 0 | -0 | -2.36 | -1.46 | -0.66 | -0.25 | 0 | -0 | Upgrade
|
Shareholders' Equity | -4.41 | -1.78 | -1.47 | -0.09 | 8.3 | 12.75 | 8.33 | -1.9 | 0.5 | -1.01 | Upgrade
|
Total Liabilities and Equity | 0.35 | 2.55 | 10.81 | 14.35 | 30.02 | 24.05 | 13.01 | 2.44 | 1.45 | 0.54 | Upgrade
|
Net Cash / Debt | -1.29 | -1.15 | -3.66 | -9.26 | -8.46 | -3.97 | -1.24 | -2.58 | -0.03 | -0.93 | Upgrade
|
Net Cash Per Share | -0.00 | -0.00 | -0.01 | -0.04 | -0.04 | -0.03 | -0.02 | -0.06 | -0.00 | -0.99 | Upgrade
|
Working Capital | -4.45 | -3.61 | -5.05 | -3.88 | -3.25 | 5.33 | 2.27 | -2.05 | -0.74 | -1.06 | Upgrade
|
Book Value Per Share | -0.01 | -0.01 | -0.01 | -0.00 | 0.04 | 0.10 | 0.11 | -0.04 | 0.02 | -1.08 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.